Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Natamycin Market - Growth, Trends and Forecasts (2017-2022) - Research and Markets

Research and Markets
Posted on: 27 Oct 17

The "Global Natamycin Market - Growth, Trends and Forecasts (2017 - 2022)" report has been added to Research and Markets' offering.

Most of the food products are infused with preservatives, in order to increase their shelf-life. Natamycin acts as a perfect preservative, due to its long-lasting effect, ability to preserve the taste, and, further, being completely natural. Most manufacturers prefer using natural preservative, as the consumers have evolved from low to high involvement buyers. Moreover, they are willing to spend more on products with higher natural contents.

Natamycin is applied as an antifungal material to the products in the food industry, as its application is considered to be the most effective and natural method for preservation. The increasing global demand for processed, dairy, and meat products is expected to boost the demand for natamycin. Most of these products are susceptible to contamination, due to the rapid growth of mould that affects the product quality and leads to its deterioration. Among most antifungal preservatives such as sorbic acid, potassium sorbate, and lactic acid, natamycin stands out due to its longer-lasting antifungal effect better than other compounds. In addition, it is completely natural that makes it a preferred additive in food industry, due to the increasing number of health-conscious consumers.

Asia-Pacific accounts for the largest market share of 33% and is expected to register the highest CAGR, during 2017-2022 (the forecast period). The natamycin market growth can be attributed to the increasing consumption of processed food and growing disposable income. Europe is one among the regions that has high potential for growth of natamycin market. North America is expected to witness comparatively slower growth than other regions, due to the non-clearance from the regulatory bodies in the region.

Companies Mentioned

  • Danisco
  • Dsm
  • Handary
  • Amtech Biotech
  • Zhejiang Silver-Elephant
  • Lanzhou Weiri
  • Langfang Meihua
  • Zhengzhou New Frey
  • Chihon Biotechnology
  • Vgp Pharmachem
  • Jiaozuojoincare
  • Beijing Oriental Rada
  • Pucheng Lifecome

Key Topics Covered:

1. Introduction

2. Research Approach and Methodology

3. Market Overview

4. Market Segmentation

5. Competitive Landscape

6. Company Profiles

For more information about this report visit

View source version on

Business Wire

Last updated on: 27/10/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.